Complete Filing Data
Sanofi reported Cash And Cash Equivalents of $7.66 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Sanofi did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profit Loss | $7.85B | $5.62B | $5.44B | $8.48B | $6.28B | $12.33B | $2.79B | $4.41B | $8.54B | $4.80B |
| Other Comprehensive Income | -$4.69B | $2.43B | -$1.60B | $2.76B | $3.31B | -$4.01B | $684.0M | $959.0M | -$2.68B | $928.0M |
| Comprehensive Income | $3.16B | $8.05B | $3.83B | $11.25B | $9.59B | $8.32B | $3.47B | $5.37B | $5.86B | $5.73B |
| Share Of Profit Loss Of Associates Accounted For Using Equity Method | -$155.0M | $60.0M | -$136.0M | $55.0M | $39.0M | $359.0M | $255.0M | $499.0M | $85.0M | $136.0M |
| Selling General And Administrative Expense | $9.54B | $9.18B | $8.93B | $8.74B | $9.56B | $9.39B | $9.88B | $9.86B | $10.07B | $9.48B |
| Revenue From Sale Of Goods | $43.63B | $41.08B | $37.82B | $37.65B | $37.76B | $36.04B | $36.13B | $34.46B | $35.07B | $33.81B |
| Research And Development Expense | $7.84B | $7.39B | $6.51B | $6.50B | $5.69B | $5.53B | $6.02B | $5.89B | $5.47B | $5.17B |
| Profit Loss From Operating Activities | $6.34B | $7.25B | $6.96B | $10.16B | $8.13B | $14.11B | $3.05B | $4.68B | $5.80B | $6.53B |
| Profit Loss Attributable To Owners Of Parent | $7.81B | $5.56B | $5.40B | $8.37B | $6.22B | $12.29B | $2.75B | $4.31B | $8.42B | $4.71B |
| Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity | $7.81B | $5.56B | $5.40B | $8.37B | $6.22B | $12.29B | $2.75B | $4.31B | -$8.42B | -$4.71B |
| Profit Loss Attributable To Noncontrolling Interests | $38.0M | $58.0M | $36.0M | $113.0M | $56.0M | $36.0M | $31.0M | $104.0M | $121.0M | $91.0M |
| Other Revenue | $3.09B | $3.21B | $3.80B | $2.91B | $1.41B | $1.33B | $1.51B | $1.21B | $1.15B | $887.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax | $179.0M | -$27.0M | -$77.0M | $431.0M | $797.0M | $14.0M | -$129.0M | -$305.0M | -$118.0M | -$128.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | -$5.22B | $2.49B | -$1.45B | $2.37B | $2.51B | -$4.02B | $813.0M | $1.26B | -$2.56B | $1.06B |
| Income Tax Relating To Components Of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | $138.0M | $18.0M | $6.0M | $204.0M | $54.0M | $39.0M | -$101.0M | -$31.0M | $90.0M | $22.0M |
| Income Tax Relating To Components Of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | $86.0M | -$19.0M | $6.0M | -$105.0M | -$78.0M | $64.0M | -$47.0M | -$71.0M | $137.0M | -$40.0M |
| Income Tax Expense Continuing Operations | $1.04B | $1.20B | $1.02B | $1.91B | $1.56B | $1.81B | $121.0M | $481.0M | $1.72B | $1.33B |
| Gross Profit | $33.67B | $31.08B | $28.99B | $28.68B | $26.92B | $25.21B | $25.65B | $24.24B | $24.61B | $24.00B |
| Cost Of Sales | $13.05B | $13.21B | $12.63B | $11.88B | $12.26B | $12.16B | $11.98B | $11.44B | $11.61B | $10.70B |
| Comprehensive Income Attributable To Owners Of Parent | $3.17B | $7.97B | $3.81B | $11.13B | $9.52B | $8.31B | $3.44B | $5.27B | $5.75B | $5.63B |
| Comprehensive Income Attributable To Noncontrolling Interests | -$6.0M | $80.0M | $23.0M | $118.0M | $67.0M | $16.0M | $30.0M | $100.0M | $106.0M | $94.0M |
| Other Adjustments To Reconcile Profit Loss | $273.0M | $68.0M | $261.0M | $120.0M | -$57.0M | -$711.0M | -$309.0M | $69.0M | $38.0M | -$83.0M |
| Income Taxes Paid Refund Classified As Operating Activities | $2.89B | $3.29B | $2.62B | $2.45B | $1.28B | $2.05B | $1.70B | $2.06B | $1.73B | -$2.10B |
| Gains Losses Recognised In Other Comprehensive Income Fair Value Measurement Entitys Own Equity Instruments | $154.0M | -$20.0M | $97.0M | $13.0M | $165.0M | $320.0M | $106.0M | -$537.0M | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $7.66B | $7.44B | $8.71B | $12.74B | $10.10B | $13.92B | $9.43B | $6.93B | $10.32B | $10.27B | $9.15B |
| Net Change In Other Current Assets And Other Current Liabilities | $2.64B | -$899.0M | $1.49B | $284.0M | $1.13B | $316.0M | $421.0M | -$814.0M | $243.0M | $541.0M | |
| Income Before Tax And Investments Accounted For Equity Method Investments | $6.18B | $6.70B | $6.25B | $9.94B | $7.80B | $13.78B | $2.75B | $4.41B | $5.53B | $5.68B | |
| Gains Losses On Cash Flow Hedges Before Tax | -$5.0M | -$6.0M | -$1.0M | $7.0M | -$6.0M | $4.0M | -$13.0M | $3.0M | -$24.0M | $31.0M | |
| Dividends Paid To Equity Holders Of Parent Classified As Financing Activities | $4.77B | $4.70B | $4.45B | $4.17B | $4.01B | $3.94B | $3.83B | $3.77B | $3.71B | $3.76B | |
| Cash Flows From Used In Operations Before Changes In Working Capital | $8.77B | $9.22B | $8.86B | $10.43B | $9.11B | $7.74B | $8.13B | $6.83B | $7.23B | $7.01B | |
| Cash Flows From Used In Operating Activities | $10.75B | $9.08B | $10.26B | $10.53B | $10.52B | $7.42B | $7.72B | $5.55B | $7.38B | $7.84B | |
| Cash Flows From Used In Investing Activities | -$2.45B | -$4.41B | -$6.20B | -$2.08B | -$7.30B | $3.62B | -$1.18B | -$12.87B | -$2.90B | -$2.51B | |
| Cash Flows From Used In Financing Activities | -$8.21B | -$5.76B | -$8.05B | -$5.82B | -$7.06B | -$6.49B | -$4.19B | $3.93B | -$7.90B | -$4.10B | |
| Amortisation Intangible Assets Other Than Goodwill | $1.78B | $1.75B | $1.91B | $1.80B | $1.58B | $1.68B | $2.15B | $2.17B | $1.87B | $1.69B | |
| Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method | -$290.0M | -$82.0M | -$293.0M | $45.0M | $15.0M | $339.0M | $192.0M | $471.0M | $47.0M | $85.0M | |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | -$352.0M | -$366.0M | -$364.0M | -$590.0M | -$300.0M | -$301.0M | -$286.0M | -$797.0M | -$97.0M | -$244.0M | |
| Adjustments For Increase Decrease In Trade Account Payable | $398.0M | $789.0M | $258.0M | $340.0M | $451.0M | $86.0M | $169.0M | $270.0M | $577.0M | $447.0M | |
| Adjustments For Deferred Tax Expense | -$2.44B | -$802.0M | -$1.23B | -$529.0M | -$356.0M | -$221.0M | -$1.77B | -$727.0M | -$909.0M | -$542.0M | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$1.20B | -$28.0M | -$472.0M | -$500.0M | $185.0M | -$134.0M | -$462.0M | -$35.0M | -$529.0M | $168.0M | |
| Actuarial Gains Losses Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset | -$163.0M | -$11.0M | $168.0M | -$622.0M | -$686.0M | $267.0M | $336.0M | -$201.0M | $28.0M | $106.0M | |
| Property Plant And Equipment | $10.05B | $10.09B | $10.16B | $9.87B | $10.03B | $9.37B | $9.72B | $9.65B | $9.58B | $10.02B | |
| Other Noncurrent Assets | $4.36B | $3.75B | $3.22B | $3.10B | $3.13B | $2.73B | $2.50B | $2.82B | $3.36B | $2.82B | |
| Other Current Assets | $4.07B | $3.83B | $3.46B | $3.53B | $3.57B | $2.74B | $2.45B | $2.02B | $2.01B | $2.21B | |
| Noncurrent Liabilities | $26.75B | $25.78B | $27.90B | $27.60B | $29.92B | $31.88B | $33.01B | $35.00B | $26.11B | $29.32B | |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | $208.0M | $13.49B | $15.0M | $85.0M | $89.0M | $83.0M | $325.0M | $68.0M | $34.0M | $6.42B | |
| Noncurrent Assets | $95.85B | $90.21B | $95.79B | $92.61B | $89.59B | $80.63B | $83.69B | $86.76B | $73.43B | $71.57B | |
| Investment Accounted For Using Equity Method | $3.26B | $316.0M | $424.0M | $677.0M | $250.0M | $201.0M | $3.59B | $3.40B | $2.85B | $2.89B | |
| Intangible Assets Other Than Goodwill | $26.26B | $22.63B | $24.32B | $21.64B | $21.41B | $18.34B | $16.51B | $21.89B | $13.08B | $10.88B | |
| Goodwill | $41.30B | $43.38B | $49.40B | $49.89B | $48.06B | $44.36B | $44.52B | $44.24B | $40.26B | $40.29B | |
| Gains Losses On Remeasuring Debt Instruments Before Tax | $11.0M | $5.0M | $21.0M | -$77.0M | -$21.0M | $15.0M | $28.0M | -$4.0M | $0.00 | ||
| Equity Attributable To Owners Of Parent | $71.38B | $77.51B | $74.04B | $74.78B | $68.68B | $63.11B | $59.06B | $58.88B | $58.07B | $57.55B | |
| Equity And Liabilities | $126.81B | $132.80B | $126.46B | $126.72B | $120.24B | $114.41B | $112.63B | $111.41B | $99.81B | $104.68B | |
| Deferred Tax Liabilities | $1.67B | $2.17B | $1.86B | $1.84B | $1.62B | $1.77B | $2.29B | $3.41B | $1.61B | $2.29B | |
| Deferred Tax Assets | $8.61B | $7.97B | $6.43B | $5.38B | $4.60B | $4.18B | $5.39B | $4.61B | $4.29B | $4.67B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Disposals Of Property Plant And Equipment Intangible Assets Other Than Goodwill Investment Property And Other Noncurrent Assets | $847.0M | $1.46B | $807.0M | $1.34B | $676.0M | $918.0M | $1.22B | $2.16B | $535.0M | $209.0M |
| Proceeds From Noncurrent Borrowings | $5.56B | $0.00 | $48.0M | $1.55B | $0.00 | $2.02B | $2.00B | $9.68B | $41.0M | $4.77B |
| Proceeds From Issuing Shares | 177.0M | 187.0M | 195.0M | 188.0M | 186.0M | 203.0M | 162.0M | 177.0M | 319.0M | 305.0M |
| Payments To Acquire Or Redeem Entitys Shares | 5.03B | 302.0M | 593.0M | 497.0M | 382.0M | 822.0M | 9.0M | 1.10B | 2.16B | 2.91B |
| Increase Decrease In Cash And Cash Equivalents | $216.0M | -$1.27B | -$4.03B | $2.64B | -$3.82B | $4.49B | $2.50B | -$3.39B | $42.0M | $1.13B |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$47.0M | -$13.0M | -$32.0M | $8.0M | $15.0M | -$64.0M | $9.0M | $1.0M | -$74.0M | -$101.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjusted Weighted Average Shares | 1.23B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.27B | 1.30B |
| Weighted Average Shares | 1.22B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | 1.26B | 1.29B |
| Dividends Paid Ordinary Shares Per Share | $3.92 | $3.76 | $3.56 | $3.33 | $3.20 | $3.15 | $3.07 | $3.03 | $2.96 | $2.93 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividends Recognised As Distributions To Noncontrolling Interests | $44.0M | $44.0M | $59.0M | $100.0M | $49.0M | $44.0M | $14.0M | $97.0M | $99.0M | $110.0M |
| Purchase Of Treasury Shares | 5.02B | 302.0M | 593.0M | 497.0M | 382.0M | 822.0M | 12.0M | 1.10B | 2.16B | 2.91B |
| Repayments Of Noncurrent Borrowings | $2.62B | $671.0M | $3.68B | $2.72B | $2.24B | $3.95B | $2.07B | $787.0M | $2.37B | $2.58B |
| Miscellaneous Other Operating Income | $1.23B | $1.09B | $979.0M | $1.81B | $859.0M | $697.0M | $783.0M | $484.0M | $237.0M | $355.0M |
| Miscellaneous Other Operating Expense | $5.66B | $4.38B | $3.44B | $2.52B | $1.81B | $1.42B | $1.21B | $548.0M | $233.0M | $482.0M |
| Gains Losses On Exchange Differences On Translation Before Tax | -$5.14B | $2.47B | -$1.46B | $2.33B | $2.46B | -$3.98B | $751.0M | $1.19B | -$3.24B | $1.09B |
| Finance Income | $394.0M | $519.0M | $584.0M | $205.0M | $40.0M | $53.0M | $141.0M | $164.0M | $147.0M | $68.0M |
| Finance Costs | $563.0M | $1.07B | $1.29B | $430.0M | $368.0M | $388.0M | $440.0M | $435.0M | $420.0M | $924.0M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | $38.0M | $38.0M | $56.0M | $97.0M | $48.0M | $44.0M | $14.0M | $14.0M | $15.0M | $21.0M |
| Adjustments For Sharebased Payments | $313.0M | $278.0M | $260.0M | $234.0M | $244.0M | $274.0M | $252.0M | $284.0M | $263.0M | $241.0M |
| Adjustments For Decrease Increase In Inventories | -$39.0M | -$477.0M | -$866.0M | -$918.0M | -$357.0M | -$593.0M | -$547.0M | -$701.0M | -$144.0M | -$326.0M |
| Dividends Recognised As Distributions To Owners Of Parent | $4.77B | $4.70B | $4.45B | $4.17B | $4.01B | $3.94B | $3.83B | $3.77B | $3.71B | $3.76B |
| Impact Of The Workdown Of Acquired Inventories Remeasured At Fair Value | $126.0M | $10.0M | $9.0M | $3.0M | $4.0M | $53.0M | $3.0M | $114.0M | -$166.0M | |
| Noncontrolling Interests | $334.0M | $350.0M | $313.0M | $368.0M | $350.0M | $146.0M | $174.0M | $159.0M | $169.0M | $170.0M |
| Longterm Borrowings | $14.25B | $11.79B | $14.35B | $14.86B | $17.12B | $19.75B | $20.13B | $22.01B | $14.33B | $16.82B |
| Inventories | $10.21B | $9.43B | $9.67B | $8.96B | $8.72B | $8.35B | $7.99B | $7.48B | $6.82B | $6.90B |
Most recent annual filing with the SEC: February 17, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.